Outset Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Outset Medical (Nasdaq: OM), a pioneering medical technology company focused on revolutionizing dialysis through cost and complexity reduction, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. Chair & CEO Leslie Trigg will deliver a presentation on Wednesday, January 15, 2025, at 8:15 a.m. Pacific time.

Interested parties can access both live and archived versions of the presentation through the company's investor relations website at investors.outsetmedical.com.

News Market Reaction – OM

-11.22%

-11.22% Session move

In the trading session that priced this news, OM declined 11.22%, reflecting a significant negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN JOSE, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that Chair & CEO Leslie Trigg will present at the 43^rd annual J.P. Morgan Healthcare conference on Wednesday, January 15, 2025, at 8:15 a.m. Pacific time.

A live and archived webcast of the presentation will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo^® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

Contact
Jim Mazzola
Vice President, Investor Relations
jmazzola@outsetmedical.com

FAQ

When is Outset Medical (OM) presenting at the 2025 J.P. Morgan Healthcare Conference?

Outset Medical will present on Wednesday, January 15, 2025, at 8:15 a.m. Pacific time.

How can investors watch Outset Medical's J.P. Morgan Healthcare Conference presentation?

Investors can watch the presentation live or access the archived webcast through Outset Medical's investor relations website at investors.outsetmedical.com.

What is the focus of Outset Medical's (OM) technology presentation at JPM 2025?

Outset Medical's presentation focuses on their first-of-its-kind technology aimed at reducing the cost and complexity of dialysis.

Who will represent Outset Medical (OM) at the 2025 J.P. Morgan Healthcare Conference?

Leslie Trigg, Chair & CEO of Outset Medical, will represent the company at the conference.